Recently, He has oriented his research toward establishing neural features associated with consciousness. he is leading a multimodal PET/fMRI study of brain mechanisms associated with the serotonin psychedelic psilocybin, to better understand how this promising and broadly applicable therapeutic affects the brain. He is collaborating with neurologists at Rigshospitalet including a project evaluating fMRI measures in coma patients to identify neural markers of conscious awareness and recovery.
Dr. Raber is a member of the faculty at the University of Southern California School of Pharmacy where he teaches classes in site-specific pharmacy practice, pharmacy standards of care, and pharmacy law. He is also a faculty member of PBI Education, a Jacksonville, Florida-based company specializing in continuing education and license remediation for healthcare professionals, where he teaches classes in pharmacy law and ethics.
Dr. Raber is an active member of the American Society of Health-System Pharmacists, California Society of Health-System Pharmacists, Academy of Managed Care Pharmacy, American College of Clinical Pharmacy, American Medical Writers Association, American Society for Healthcare Risk Management, Southern California Association for Healthcare Risk Management, and the American Society for Pharmacy Law.
This section has yet to be updated by the user.